XML 19 R9.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 28, 2025
Sep. 29, 2024
Cash flows from operating activities:    
Net income $ 296,827 $ 396,119
Adjustments to reconcile net income from operations to net cash provided by operating activities:    
Depreciation 79,484 74,480
Stock-based compensation 47,561 45,267
Equity in net earnings of affiliate 16,709 1,075
Losses (gains) on investments (4,722) 10,139
Provision for excess and obsolete inventory 19,175 15,516
Amortization 12,723 14,133
Gain on sale of business 0 (57,486)
Deferred taxes (29,100) (26,261)
Retirement plan losses (gains) (673) (2,512)
Other 3,344 (5,041)
Changes in operating assets and liabilities, net of businesses acquired:    
Accounts receivable (111,787) (65,266)
Inventories (34,618) 11,127
Prepayments and other assets (22,599) 61,438
Accounts payable and other liabilities 121,447 (63,666)
Deferred revenue and customer advances 25,652 3,624
Retirement plans contributions (6,986) (4,169)
Income taxes (19,661) (18,898)
Net cash provided by operating activities 392,776 389,619
Cash flows from investing activities:    
Purchases of property, plant and equipment (161,121) (140,710)
Acquisition of businesses, net of cash acquired (144,380) 0
Purchase of investment in a business (25,519) (527,060)
Purchases of marketable securities (27,465) (35,097)
Proceeds from the sale of a business, net of cash and cash equivalents sold 0 90,348
Proceeds from maturities of marketable securities 41,621 33,163
Proceeds from sales of marketable securities 9,172 23,600
Proceeds from insurance 0 873
Net cash used for investing activities (307,692) (554,883)
Cash flows from financing activities:    
Proceeds from borrowings on revolving credit facility 200,000 185,000
Repayments of borrowings on revolving credit facility 0 (185,000)
Dividend payments (57,574) (56,936)
Repurchase of common stock (518,658) (55,053)
Payments related to net settlement of employee stock compensation awards (15,254) (13,833)
Issuance of common stock under stock purchase and stock option plans 30,076 37,265
Net cash used for financing activities (361,410) (88,557)
Effects of exchange rate changes on cash and cash equivalents (4,328) 6,286
Decrease in cash and cash equivalents (280,654) (247,535)
Cash and cash equivalents at beginning of period 553,354 757,571
Cash and cash equivalents at end of period 272,700 510,036
Non-cash investing activities:    
Capital expenditures incurred but not yet paid: $ 7,821 $ 3,679